In vivo and in vitro experimental studies showed that there was significant ferroptosis in addition to apoptosis in MON-P53-treated cells, which not only inhibited tumor growth, but also led to an extended lifespan in tumor-bearing mice [47]. The gene discussed is TP53; the disease is neoplasm.